Mustang Bio, Inc.
COMBINATION THERAPY COMPRISING CANCER-TARGETED CAR-T CELLS AND A METHOD OF USING SAME FOR A TREATMENT FOR CANCER
Last updated:
Abstract:
Described are improved methods for treating solid tumors, such as malignant gliomas, with a dual approach utilizing a CAR-T immunotherapy and a viral oncolytic therapy.
Status:
Application
Type:
Utility
Filling date:
9 Sep 2021
Issue date:
10 Mar 2022